Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Non-Invasive Screening for Fetal Aneuploidy
A Prospective Clinical Study to Evaluate a Novel Non-invasive Prenatal Screening Method for Characterizing Fetal Whole Chromosome Aberrations and Other Major Defects and Deletions Found in the Maternal Blood.
Status: Enrolling
Updated:  12/31/1969
Obstetrix Medical Group of Houston
mi
from
The Woodlands, TX
Non-Invasive Screening for Fetal Aneuploidy
A Prospective Clinical Study to Evaluate a Novel Non-invasive Prenatal Screening Method for Characterizing Fetal Whole Chromosome Aberrations and Other Major Defects and Deletions Found in the Maternal Blood.
Status: Enrolling
Updated: 12/31/1969
Obstetrix Medical Group of Houston
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Louis Stokes VA Medical Center, Cleveland, OH
mi
from
Cleveland, OH
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Louis Stokes VA Medical Center, Cleveland, OH
mi
from
Cleveland, OH
Click here to add this to my saved trials
Family Access to Dentist Study
Family Intervention With Caregivers of Children With Dental Needs
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Family Access to Dentist Study
Family Intervention With Caregivers of Children With Dental Needs
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Family Access to Dentist Study
Family Intervention With Caregivers of Children With Dental Needs
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Family Access to Dentist Study
Family Intervention With Caregivers of Children With Dental Needs
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome
Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome: A Randomized, Double-blinded, Placebo-controlled Prospective Study
Status: Enrolling
Updated:  12/31/1969
University of Vermont Medical Center
mi
from
Burlington, VT
Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome
Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome: A Randomized, Double-blinded, Placebo-controlled Prospective Study
Status: Enrolling
Updated: 12/31/1969
University of Vermont Medical Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Status: Enrolling
Updated:  12/31/1969
SIUSOM - Division of Urology
mi
from
Springfield, IL
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Status: Enrolling
Updated: 12/31/1969
SIUSOM - Division of Urology
mi
from
Springfield, IL
Click here to add this to my saved trials
Aging, Cognition, and Hearing Evaluation in Elders Study
Aging, Cognition, and Hearing Evaluation in Elders Pilot Study
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Comstock Center for Public Health Research
mi
from
Hagerstown, MD
Aging, Cognition, and Hearing Evaluation in Elders Study
Aging, Cognition, and Hearing Evaluation in Elders Pilot Study
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Comstock Center for Public Health Research
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Lucile Packard Children's Hospital Stanford University
mi
from
Palo Alto, CA
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Lucile Packard Children's Hospital Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
National Cancer Institute
mi
from
Rockville, MD
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
National Cancer Institute
mi
from
Rockville, MD
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
mi
from
Washington,
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study
MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study
Status: Enrolling
Updated:  12/31/1969
UCSF School of Dentistry - Dental Offices in Bay Area
mi
from
San Francisco, CA
MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study
MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study
Status: Enrolling
Updated: 12/31/1969
UCSF School of Dentistry - Dental Offices in Bay Area
mi
from
San Francisco, CA
Click here to add this to my saved trials
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Xanthohumol and Prevention of DNA Damage
Prevention of Oxidative DNA Damage by Xanthohumol
Status: Enrolling
Updated:  12/31/1969
Oregon State University
mi
from
Corvallis, OR
Xanthohumol and Prevention of DNA Damage
Prevention of Oxidative DNA Damage by Xanthohumol
Status: Enrolling
Updated: 12/31/1969
Oregon State University
mi
from
Corvallis, OR
Click here to add this to my saved trials
Investigation of the Safety of Intranasal Glulisine in Down Syndrome
A Double-Blind, Placebo-Controlled Pilot Investigation of the Safety of Intranasal Glulisine in Down Syndrome
Status: Enrolling
Updated:  12/31/1969
HealthPartners Neuroscience Center
mi
from
Saint Paul, MN
Investigation of the Safety of Intranasal Glulisine in Down Syndrome
A Double-Blind, Placebo-Controlled Pilot Investigation of the Safety of Intranasal Glulisine in Down Syndrome
Status: Enrolling
Updated: 12/31/1969
HealthPartners Neuroscience Center
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Arizona Allergy Associates
mi
from
Chandler, AZ
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Arizona Allergy Associates
mi
from
Chandler, AZ
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine
mi
from
Irvine, CA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
University California San Diego - Rady's Children's Hospital
mi
from
San Diego, CA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
University California San Diego - Rady's Children's Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Immunoe International Research
mi
from
Centennial, CO
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Immunoe International Research
mi
from
Centennial, CO
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Allergy Associate of the Palm Beaches
mi
from
North Palm Beach, FL
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Allergy Associate of the Palm Beaches
mi
from
North Palm Beach, FL
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Optimed Research, LTD
mi
from
Columbus, OH
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Optimed Research, LTD
mi
from
Columbus, OH
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Oklahoma Institute of Allergy & Asthma Clinical Research
mi
from
Oklahoma City, OK
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Oklahoma Institute of Allergy & Asthma Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Pennsylvania State University
mi
from
Hershey, PA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Pennsylvania State University
mi
from
Hershey, PA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Dallas Allergy Immunology
mi
from
Dallas, TX
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Dallas Allergy Immunology
mi
from
Dallas, TX
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
AARA Research Center
mi
from
Dallas, TX
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
AARA Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
O&O Alpan
mi
from
Fairfax, VA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
O&O Alpan
mi
from
Fairfax, VA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Bellingham Asthma Allergy Clinic
mi
from
Bellingham, WA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Bellingham Asthma Allergy Clinic
mi
from
Bellingham, WA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin/Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin/Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Cardinal Glennon Children's Medical Center
mi
from
Minneapolis, MN
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Cardinal Glennon Children's Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
North Shore University Hospital
mi
from
Manhasset, NY
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
New York, NY
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
North Austin Maternal Fetal Medicine
mi
from
Austin, TX
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
North Austin Maternal Fetal Medicine
mi
from
Austin, TX
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
Cooper University Hospital
mi
from
Camden, NJ
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
Virtua
mi
from
Mount Laurel, NJ
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
Virtua
mi
from
Mount Laurel, NJ
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
St. Peter's University
mi
from
New Brunswick, NJ
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
St. Peter's University
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
Complete Women's Healthcare
mi
from
Garden City, NY
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
Complete Women's Healthcare
mi
from
Garden City, NY
Click here to add this to my saved trials